Skip to main content
logo
Mangoceuticals, Inc. (MGRX)
NASDAQ: MGRX · Real-Time Price · USD
0.5330
-0.0130 (-2.38%)
At close: Aug 12, 2026, 4:00 PM EDT
0.5500
+0.0170 (3.19%)
After-hours: Aug 12, 2026, 4:02 PM EDT

Mangoceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Net Income
-19.21-20.64-8.71-9.21-2
Depreciation & Amortization
1.61.720.730.020
Stock-Based Compensation
11.5711.882.352.160.77
Other Adjustments
0.070.210.10.05-0.15
Changes in Inventories
----0.02-
Changes in Accounts Payable
-0.20.060.630.110.03
Changes in Other Operating Activities
-0.130.910.03-0.1-0.01
Operating Cash Flow
-4.89-5.85-4.86-7-1.35
Operating Cash Flow Growth
-----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Capital Expenditures
----0-0.04
Sale of Property, Plant & Equipment
--0.07--
Investing Cash Flow
--0.07-0-0.04

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Long-Term Debt Issued
-0.680.15-0.080.08
Long-Term Debt Repaid
--0.21--0.09-0.03
Net Long-Term Debt Issued (Repaid)
-0.470.15-0.170.05
Issuance of Common Stock
4.425.551.337.222
Net Common Stock Issued (Repurchased)
4.425.551.337.222
Issuance of Preferred Stock
-1.050.12.65--
Net Preferred Stock Issued (Repurchased)
-1.050.12.65--
Other Financing Activities
-1.15---
Financing Cash Flow
4.997.274.137.062.05

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Foreign Exchange Rate Adjustments
-00.01-0.01--
Net Cash Flow
-1.311.42-0.670.060.66

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-4.89-5.85-4.86-7-1.39
Free Cash Flow Growth
-----
FCF Margin
-1178.74%-1282.89%-789.74%-957.07%-15545.60%
Free Cash Flow Per Share
-0.37-0.58-2.46-6.52-1.93
Levered Free Cash Flow
-17.93-17.49-7.16-9.37-1.97
Unlevered Free Cash Flow
-15.03-16.47-7.3-9.21-2.01
SEC Filings: 10-K · 10-Q